These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17971032)

  • 1. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
    Xiang J; Gu X; Qian S; Chen Z
    Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
    Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
    Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
    Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.
    Chen J; He Q; Zhang R; Chu Y; Wang Y; Liu Q; Xiong S
    Clin Exp Immunol; 2004 Nov; 138(2):245-50. PubMed ID: 15498033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
    Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
    J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells.
    Jiga LP; Ehser S; Kleist C; Opelz G; Terness P
    Transplantation; 2007 Feb; 83(3):347-50. PubMed ID: 17297411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 12. Recipient dendritic cells modified by RNA interference targeting CD80 and CD86 elicit T cell hyporesponsiveness via enhanced T cell apoptosis.
    Hong J; Gu XD; Xiang JB; Zhang Z; Zang YW; Zhang QH; Qian SG; Chen ZY
    Chin Med J (Engl); 2013; 126(11):2139-44. PubMed ID: 23769573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S; Ahmed A; Malu S; Nandi D
    J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.
    Orabona C; Grohmann U; Belladonna ML; Fallarino F; Vacca C; Bianchi R; Bozza S; Volpi C; Salomon BL; Fioretti MC; Romani L; Puccetti P
    Nat Immunol; 2004 Nov; 5(11):1134-42. PubMed ID: 15467723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis.
    Jordan JM; Woods ME; Feng HM; Soong L; Walker DH
    J Infect Dis; 2007 Aug; 196(4):629-38. PubMed ID: 17624851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?
    Hamano K; Bashuda H; Ito H; Shirasawa B; Okumura K; Esato K
    J Surg Res; 2000 Sep; 93(1):28-34. PubMed ID: 10945940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
    Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
    Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.